Home>>(S)-(+)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide

(S)-(+)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide

Catalog No.GC41728

N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.

Products are for research use only. Not for human use. We do not sell to patients.

(S)-(+)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide Chemical Structure

Size Price Stock
1mg
$111.00
Please Inquire
5mg
$502.00
Please Inquire
10mg
$891.00
Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. Docosahexaenoyl ethanolamide (DHEA) has potential signaling roles in cancer, inflammation, and neurological development and functioning. At least some of DHEA's effects are mediated through cannabinoid (CB) receptors, while some NAEs also act as vanilloid receptor agonists and voltage-gated K+ channel blockers. (S)-(+)-Docosahexaenyl-2'-hydroxy-1'-propylamide is a homolog of DHEA, characterized by the addition of an (S)-β-methyl group at the terminal ethanolamine carbon. A similar modification of arachidonoyl ethanolamide to produce S-2 methanandamide imparts higher affinity for the CB receptor. The physiological actions of this compound have not been evaluated.

Reviews

Review for (S)-(+)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (S)-(+)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.